Quantason has developed IDUS™, a revolutionary, next-generation bi-modal platform which fundamentally changes the utilization of conventional ultrasound as a modality for diagnostic imaging and active screening. Quantason's patented and patent-pending technology expands the capabilities of conventional ultrasound systems by combining anatomical 2D imaging with proprietary, real-time stimulation sequences to detect, 3D locate, and classify micron-size target(s) - previously conceived outside of ultrasound capabilities - based on their response signature(s). For more information, visit www.quantason.com.
| Website | http://www.quantason.com |
| Revenue | $8 million |
| Employees | 2 (0 on RocketReach) |
| Address | 13412 Ventura Blvd Ste 250, Sherman Oaks, California 91423, US |
| Phone | +1 310-990-0184 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Delphinus Medical Technologies, Inc., National Ultrasound, Inc., Fischer Imaging (view competitors) |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 33 Companies, NAICS Code 334 Companies |
Looking for a particular QUANTASON, LLC employee's phone or email?
QUANTASON, LLC Questions
The QUANTASON, LLC annual revenue was $8 million in 2026.
QUANTASON, LLC is based in Sherman Oaks, California.
The NAICS codes for QUANTASON, LLC are [33, 334].
The SIC codes for QUANTASON, LLC are [384, 38].
